-
-
-
Whether a bite or sting results in an anaphylactic reaction, impressive
local effects, or a life-threatening systemic reaction, the emergency
physician must be able to institute appropriate and effective
treatment. Emergency physicians also must be able to recognize clinical
envenomation patterns, since some critically ill patients may not be
able to convey the details of the attack. Since all areas of the
country are represented in the envenomation statistics, all emergency
physicians should be familiar with identification and stabilization of
envenomated patients and know what resources are available locally for
further management of these often complicated patients.
-
Since 1996, at least 150 children have died as a result of being trapped in hot, parked vehicles. Contrary to what would be expected, these deaths occurred throughout all regions of the United States, making it important for all emergency medicine physicians to be familiar with the resuscitation of a child with a heat-related illness. This article provides an overview of heat-related illnesses in children and prevention and management strategies to facilitate care.
-
-
This issue is the second and final part in our series on urinary tract infection. Part I of the series examined epidemiology, emerging resistance patterns, and patient-specific treatment strategies. In part II, we will cover antibiotic selection, new treatment options, and special considerations.
-
In one of the more bizarre stories of the year, the FDA has uncovered files of counterfeit Procrit (epoetin alfaJohnson & Johnson) in routine surveillance. To make matters worse, the fake vials have been contaminated with bacteria and many contain no active ingredient.
-
-
Nationally, its estimated that patients need the services of 30,000 intensivists. since only about 6,000 board-certified intensivists are available, theres a big gap to be filled, and one company offering online clinical services has started filling it.
-
In this large, randomized trial, critically ill patients who received weekly doses of recombinant human erythropoietin had higher hemoglobin levels and required fewer transfusions than placebo-treated patients.